Adams Diversified Equity Fund, Inc. Cara Therapeutics, Inc. Transaction History

Adams Diversified Equity Fund, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 26, 2019	SELL	$14.41 - $19.64 $331,430 - $451,720	-23,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$12.45 - $23.47 $73,455 - $138,473	5,900 Added 34.5%	23,000 $299,000
Q3 2018 Oct 29, 2018	BUY	$17.57 - $23.95 $300,447 - $409,545	17,100 New	17,100 $410,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14.5M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.